Sanara Q1 FY26 net income turns to USD 397,687; revenue rises 19% to USD 27.8 million

Sanara MedTech, Inc.

SMTI

0.00

Sanara MedTech first-quarter net revenue rose 19% to USD 27.8 million.
Net income from continuing operations swung to profit of USD 397,687, or USD 0.04 per diluted share.
Operating income climbed to USD 2.6 million; gross margin improved 1 percentage point to 93%.
Adjusted EBITDA increased 58% to USD 4.3 million; cash fell to USD 13.6 million while long-term debt edged up to USD 46.2 million.
Sales team expanded to 43 reps; products were contracted or approved in over 4,000 hospitals and ambulatory surgery centers, sold in over 1,400 facilities, with agreements covering more than 450 distributors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanara Medtech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605111650PRIMZONEFULLFEED9717826) on May 11, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.